News Conference News ESC 2016 NIPPON: With Nobori Stent, 6 Months of DAPT as Safe and Effective as 18 Months Michael O'Riordan August 28, 2016
News Daily News Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI Michael O'Riordan August 24, 2016
News Conference News EuroPCR 2016 Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS Michael O'Riordan May 17, 2016
News Daily News Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond December 23, 2015
News Features From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing Todd Neale November 08, 2015
News Industry News CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System September 21, 2015
News Industry News First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate) July 29, 2015
Presentation Cardiovascular Interventions 2014 How to Manage Post PCI Antiplatelet Therapy in the Patient on Oral Anticoagulation Presenter: David P. Faxon October 23, 2014
Presentation TCT 2013 Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives Presenter: Eugenia Nikolsky October 28, 2013
News Daily News ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI September 30, 2013